Furthermore, it has been uncovered that the stimulation of OX1R may play a critical role in the development of pancreatic cancer and could serve as a promising therapeutic target for individuals with pancreatic cancer. This evidence concerns the gene HCRTR1 and pancreatic neoplasm.